Skip to main content
SpringerLink
Log in

99mTc-Annexin A5 Uptake and Imaging to Monitor Chemosensitivity

  • Protocol
Chemosensitivity: Volume II

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 111))

Abstract

Most anticancer agents act by inducing apoptosis in sensitive tumor cells. Hence, in many types of cancers, significant increase of tumor apoptosis after chemotherapy correlates with tumor chemosensitivity. Theoretically, a reliable evaluation of apoptotic changes, postchemotherapy to baseline, may provide valuable insights into the apoptotic competence of cancers. Until now, assessment of chemosensitivity has usually relied upon histological evidence of tumor response (i.e., partial or complete disappearance of tumor cells) or demonstration of tumor shrinkage by means of morphological imaging (i.e., computed tomography or magnetic resonance imaging). In clinical practice, however, these conventional methods are proving ineffective for monitoring tumor chemosensitivity on a daily basis. Recent developments in molecular imaging have allowed the synthesis of a new radiolabeled agent, 99mTc-recombinant human Annexin A5, designed to the assessment of apoptotic response of cancers after a single course of chemotherapy. Such in vivo technique opens promising perspectives for evaluating, noninvasively and early, tumor response to anticancer therapies. Alternative methods for Annexin A5 labeling and imaging may improve the detection of drug-induced apoptosis to monitor chemosensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Staunton, M. J. and Gaffney, E. F. (1995) Tumor type is a determinant of suscep tibility to apoptosis. Am. J. Clin. Pathol. 103, 300–307.

    Article  CAS  PubMed  Google Scholar 

  2. Symmans, W. R, Volm, M. D., Shapiro, R. L., et al. (2000) Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatments. Clin. Cancer Res. 6, 4610–4617.

    CAS  PubMed  Google Scholar 

  3. Ghosh, M., Crocker, J., and Morris, A. (2001) Apoptosis in squamous cell carci noma of the lung: correlation with survival and clinicopathological features. J. Clin. Pathol. 54, 111–115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fox, E., Curt, G. A., and Balis, F. M. (2002) Clinical trial design for target-based therapy. Oncologist 7, 401–407.

    Article  CAS  PubMed  Google Scholar 

  5. Dive, C., Evans, C. A., and Whetton, A. D. (1992) Induction of apoptosis-new targets for cancer chemotherapy. Semin. Cancer Biol. 3, 417–427.

    CAS  PubMed  Google Scholar 

  6. Workman, P. (2002) Challenges of PK/PD measurements in modern drug devel opment. Eur. J. Cancer 38, 2189–2193.

    Article  CAS  PubMed  Google Scholar 

  7. Workman, P. and Kaye, S. B. (2002) Translating basic cancer research into new cancer therapeutics. Trends Mol. Med. 4(Suppl.), S1–S9.

    Article  Google Scholar 

  8. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., et al. (2000) New guidelines to evaluate response to treatment in solid tumors. J. Natl. Cancer Inst. 92, 205–216.

    Article  CAS  PubMed  Google Scholar 

  9. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V. (1994) Apoptosis-its signif icance in cancer and cancer therapy. Cancer 73, 2013–2026.

    Article  CAS  PubMed  Google Scholar 

  10. Hickman, J. A. (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121–139.

    Article  CAS  PubMed  Google Scholar 

  11. Kaufmann S. H. and Earnshaw W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42–49.

    Article  CAS  PubMed  Google Scholar 

  12. Mow, B. M. E, Blajeski, A. L., Chandra, J., and Kaufman, S. H. (2001) Apopto sis and the response to anticancer therapy. Curr. Opin. Oncol. 13, 453–462.

    Article  CAS  PubMed  Google Scholar 

  13. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., et al. (1995) Early redistri bution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by over expression of Bcl-2 and Abl. J. Exp. Med. 182, 1545–1556.

    Article  CAS  PubMed  Google Scholar 

  14. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207–2216.

    CAS  PubMed  Google Scholar 

  15. Huber, R., Berendes, R., Burger, A., et al. (1992) Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane bind ing and ion channel formation of the annexin family of proteins. J. Mol. Biol. 223, 683–704.

    Article  CAS  PubMed  Google Scholar 

  16. Reutelingsperger, C. P. M. (2001) Annexins: key regulators of haemostasis, thrombosis, and apoptosis. Thromb. Haemost. 86, 413–419.

    CAS  PubMed  Google Scholar 

  17. Mesner, P. W. and Kaufmann, S. H. (1997) Methods utilized in the study of apoptosis. Adv. Pharmacol. 41, 57–87.

    Article  CAS  PubMed  Google Scholar 

  18. Blankenberg, F. G., Katsikis, P. D., Tait, J. R, et al. (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA 95, 6349–6354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Blankenberg, F. G., Katsikis, P. D., Tait, J. F., et al. (1999) Imaging of apoptosis (programmed cell death) with 99mTc Annexin V. J. Nucl. Med. 40, 184–191.

    CAS  PubMed  Google Scholar 

  20. Ohtsuki, K., Akashi, K., Aoka, Y., et al. (1999) Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur. J. Nuclear Med. 26, 1251–1258.

    Article  CAS  Google Scholar 

  21. Vriens, P. W., Blankenberg, F. G., Stoot, J. H., et al. (1998) The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejec tion. J. Thorac. Cardiovasc. Surg. 116, 844–853.

    Article  CAS  PubMed  Google Scholar 

  22. Ogura, Y., Krams, S. M., Martinez, O. M., et al. (2000) Radiolabeled Annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 214, 795–800.

    Article  CAS  PubMed  Google Scholar 

  23. Blankenberg, F. G., Robbins, R. C., Stoot, J. H., et al. (2000) Radionucleide imag ing of acute lung transplant rejection with annexin V. Chest, 117, 834–840.

    Article  CAS  PubMed  Google Scholar 

  24. D’Arceuil, H., Rhine, W., de Crespigny, A., et al. (2000) 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 31, 2692–2700.

    Article  PubMed  Google Scholar 

  25. Blankenberg, F. G., Naumovski, L., Tait, J. F., Post, A. M., and Strauss, H. W. (2001) Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J. Nucl. Med. 42, 309–316.

    CAS  PubMed  Google Scholar 

  26. Hofstra, L., Liem, I. H., Dumont, E. A., et al. (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209–212.

    Article  CAS  PubMed  Google Scholar 

  27. Narula, J., Acio, E. R., Narula, N., et al. (2001) Annexin-V imaging for noninva sive detection of cardiac allograft rejection. Nat. Med. 7, 1347–1352.

    Article  CAS  PubMed  Google Scholar 

  28. Kown, M. H., Strauss, H. W., Blankenberg, F. G., et al. (2001) In vivo imaging of acute cardiac rejection in human patients using 99mtechnetium labeled Annexin V. Am. J. Transpl. 1, 270–277.

    Article  CAS  Google Scholar 

  29. Hofstra, L., Thimister, P. W. L., DeBruine, A. P., et al. (2001) In vivo detection of apoptosis in an intracardiac tumor. JAMA 14, 1841.

    Article  Google Scholar 

  30. Mochizuki, T., Kuge, Y., Zhao, S., et al. (2003) Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-Annexin V. J. Nuclear Med. 44, 92–97.

    CAS  Google Scholar 

  31. Belhocine, T. Z., Steinmetz, N., Hustinx, R., et al. (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8, 2766–2774

    CAS  PubMed  Google Scholar 

  32. Kasina, S., Rao, T. N., Srinivasan, A., et al. (1991) Development and biologic eval uation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. J. Nuclear Med. 32, 1445–1450.

    CAS  Google Scholar 

  33. Green, A. M. and Steinmetz, M. D. (2002) Monitoring apoptosis in real time. Cancer J. 8, 82–92.

    Article  PubMed  Google Scholar 

  34. Kemerink, G. J., Boersma, H. H., Thimister, P. W. L., et al. (2001) Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Eur. J. Nuclear Med. 28, 1373–1378.

    Article  CAS  Google Scholar 

  35. Kemerink, G. J., Liu, X., Kieffer, D., et al. (2003) Safety, biodistribution, and dosimetry of 99mTc-HYNIC-Annexin V, a novel human recombinant Annexin V for human application. J. Nuclear Med. 44, 947–952.

    CAS  Google Scholar 

  36. Subbarayan, M., Häfeli, U. O., Feyes, D. K., Unnithan, J., Emancipator, S. N., and Mukhtar, H. (2003) A simplified method for preparation of 99mTc-Annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J. Nuclear Med. 44, 650–656.

    CAS  Google Scholar 

  37. Blankenberg, F. G., Tait, J., and Strauss, H. W. (2000) Apoptotic cell death: its implications for imaging in the next millennium. Eur. J. Nuclear Med. 27, 359–367.

    Article  CAS  Google Scholar 

  38. Yang, D. J., Azhdarinia, A., Wu, P., et al. (2001) In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-Annexin V. Cancer Biother. Radiopharm. 16, 73–83.

    Article  PubMed  Google Scholar 

  39. Tait, J. E, Brown, D. S., Gibson, D. E, Blankenberg, EG., and Strauss, H. W. (2000) Development and characterization of Annexin V mutants with endogenous chelation sites for 99mTc. Bioconjugate Chem. 11, 918–925.

    Article  CAS  Google Scholar 

  40. Ke, S., Wen, X., Wu, Q.-P., et al. (2004) Imaging taxane-induced tumor apoptotic using PEGylated, 111in-labeled Annexin V. J. Nuclear Med. 45, 108–115.

    CAS  Google Scholar 

  41. Lahorte, C, Siegers, G., Philippe, J., Van de Wiele, C., and Dierckx, R. A. (2001) Synthesis and in vitro evaluation of 123I-labelled human recombinant Annexin V. Bio. Eng. 17, 51–53.

    CAS  Google Scholar 

  42. Ito, M., Tomiyoshi, K., Takahashi, N., et al. (2002) Development of a new ligand, 11C-labeled Annexin V, for PET imaging of apoptosis. Proc. SNM 49th Annual Meeting, No. 1457.

    Google Scholar 

  43. Russell, J., O’Donoghue, J. A., Finn, R., Finn, R., et al. (2002) Iodination of Annexin V for imaging apoptosis. J. Nuclear Med. 43, 671–677.

    CAS  Google Scholar 

  44. Glaser, M., Collingridge, D. R., Aboagye, E., et al. (2003) Iodine-124 labelled Annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl. Radiat. Isot. 58, 55–62.

    Article  CAS  PubMed  Google Scholar 

  45. Dekker, B., Keen, H., Zweit, J., et al. (2002) Detection of cell death using 124I-Annexin V. Proc. SNM 49th Annual Meeting, No. 256.

    Google Scholar 

  46. Keen, H., Dekker, B., Disley, L., et al. (2003) Iodine-124 labelled Annexin V for PET imaging of in vivo cell death. Proc. SNM 50th Annual Meeting, No. 586.

    Google Scholar 

  47. Smith-Jones, P. M., Afroze, A., Zanzonico, P., Tait, J., Larson, S. M., and Strauss, H. W. (2003) 68Ga labelling of Annexin-V: comparison to 99mTc-Annexin-V and 67Ga-Annexin. Proc. SNM 50th Annual Meeting, No. 159.

    Google Scholar 

  48. Zijlstra, S., Gunawan, J., and Burchert, W. (2003) Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantifica tion of apoptotic cells with PET. Appl. Radiat. Isot. 58, 201–207.

    Article  CAS  PubMed  Google Scholar 

  49. Vaidayanathan, G. and Zalutsky, M. R. (1992) Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate. Int. J. Rad. Appl. Instrum. B 19, 275–281.

    Article  Google Scholar 

  50. Boisgard, R., Blondel, A., Dolle, F., et al. (2003) A new 18F tracer for apoptosis imaging in tumor bearing mice. Proc. SNM 50th Annual Meeting, No. 157.

    Google Scholar 

  51. Mease, R. C., Weinberg, I. N., Toretsky, J. A., and Tait, J. F. (2003) Preparation of F-18 labeled Annexin V: a potential PET radiopharmaceutical for imaging cell death. Proc. SNM 50th Annual Meeting, No. 1058.

    Google Scholar 

  52. Beyer, T., Townsend, D. W., Brun, T., et al. (2000) A combined PET/CT scanner for clinical oncology. J. Nuclear Med. 41, 1369–1379.

    CAS  Google Scholar 

  53. Townsend, D. W. and Beyer, T. (2002) A Combined PET/CT scanner: the path to true image fusion. Br. J. Radiol. 75(Suppl.), S24–30.

    Article  PubMed  Google Scholar 

  54. Steinert, H. C. and von Schulthess, G. K. (2002) Initial clinical experience using a new integrated in-line PET/CT system. Br. J. Radiol. 75(Suppl.), S36–S38.

    Article  PubMed  Google Scholar 

  55. Takei, T., Kuge, Y., Zhao, S., et al. (2003) The time course of apoptotic tumor response following a single dose of chemotherapy: evaluation with 99mTc-Annexin V, caspase-3, expression and TUNEL staining in an experimental tumor model. Proc. SNM 50th Annual Meeting, No. 583.

    Google Scholar 

  56. Blankenberg, F. (2002) To scan or not scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clin. Cancer Res. 8, 2757–2758.

    PubMed  Google Scholar 

  57. Geske, F. J., Monks, J., Lehman, L., and Fadok, V. A. (2002) The role of the macrophages in apoptosis: hunter, gatherer, and regulator. Int. J. Hematol. 76, 16–26.

    Article  PubMed  Google Scholar 

  58. Geske, F. J., Monks, J., Lehman, L., and Fadok, V. A. (2001) Early stages of p53 induced apoptosis are reversible. Cell Death Differ. 8, 182–191.

    Article  CAS  PubMed  Google Scholar 

  59. Hammill, A. K., Urh, J. W., and Scheuermann, R. H. (1999) Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp. Cell Res. 251, 16–21.

    Article  CAS  PubMed  Google Scholar 

  60. Martin, S., Pombo, I., Poncet, P., David, B., Arock, M., and Blank, U. (2000) Immunologic stimulation of mast cells leads to reversible exposure of phos phatidylserine in the absence of apoptosis. Int. Arch. Allergy Immunol. 123, 249–258.

    Article  CAS  PubMed  Google Scholar 

  61. Allman, R., Errington, R. J., and Smith, P. J. (2003) Delayed expression of apop tosis in human lymphoma cells undergoing low-dose Taxol-induced mitotic stress. Br. J. Cancer 88, 1649–1658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Jules Bordet Cancer Institute, Brussels, Belgium

    Tarik Z. Belhocine

  2. Division Pediatric Radiology, Stanford University School of Medicine, Palo Alto, CA, USA

    Francis G. Blankenberg

Authors
  1. Tarik Z. Belhocine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francis G. Blankenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Garden State Cancer Center, Belleville, NJ, USA

    Rosalyn D. Blumenthal

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Belhocine, T.Z., Blankenberg, F.G. (2005). 99mTc-Annexin A5 Uptake and Imaging to Monitor Chemosensitivity. In: Blumenthal, R.D. (eds) Chemosensitivity: Volume II. Methods in Molecular Medicine™, vol 111. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-889-7:363

Download citation

  • DOI: https://doi.org/10.1385/1-59259-889-7:363

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-586-6

  • Online ISBN: 978-1-59259-889-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation